{"url_path":"/sec/eltx/8-k/2026-07-02/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1601485/0001104659-26-080058-index.html","accession_number":"0001104659-26-080058","cik":"0001601485","ticker":"ELTX","issuer_name":"Elicio Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1601485/0001104659-26-080058-index.html","primary_entity_key":"0001601485","primary_entity_name":"Elicio Therapeutics, Inc."},"word_count":43,"has_tables":true,"body_markdown":"**Item 8.01. Other Events**\n\n \n\nOn July 1, 2026, the Company issued a press release (the “Pricing\nPress Release”) announcing the pricing of the Offering. A copy of the Pricing Press Release is attached hereto as Exhibit 99.1 and\nis incorporated by reference herein."}